Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
NO-13065 by Otsuka Pharmaceutical for Obesity: Likelihood of Approval
NO-13065 is under clinical development by Otsuka Pharmaceutical and currently in Phase I for Obesity. According to GlobalData, Phase I...